Company: SCLXW
Filing Date: 2025-05-16
Form Type: DEF 14A
Source: 0000950170-25-073612
Chunk: 12

Company: Scilex Holding Co
Filing Date: 2025-05-16
Form: DEF 14A
Chunk 12
---
 Corporate Secretary at the address set forth above for a copy of the relevant provisions of our Bylaws regarding the requirements for making stockholder proposals and nominating director candidates.

How is your reverse stock split effected in April 2025 reflected in this Proxy Statement?

On April 15, 2025, we effected a 1-for-35 reverse split of our common stock (the “Reverse Stock Split”). Unless indicated otherwise, all share and per share amounts for all periods presented in this Proxy Statement have been adjusted retroactively, where applicable, to reflect this Reverse Stock Split.

<div align='center'>11</div>

BOARD OF DIRECTORS AND CORPORATE GOVERNANCE Our business and affairs are managed under the direction of our Board. Our Board consists of six directors, all of whom, other than Jaisim Shah and Henry Ji, Ph.D., qualify as “independent” under The Nasdaq Stock Market LLC (“Nasdaq”) listing rules and standards (the “Nasdaq Listing Rules”), including Rule 5605(a)(2) of the Nasdaq Listing Rules. Our Board is divided into three staggered classes of directors. At each annual meeting of stockholders, a class of directors will be elected for a three-year term to succeed the class whose term is then expiring. The following table sets forth the name, age as of May 1, 2025, and certain other information for each of the members of our Board with terms expiring at the Annual Meeting (who are also nominees for election as a director at the Annual Meeting) and for each of the continuing members of our Board:

|                                                              | Class | Age | Position(s)                                     | Director Since | Current Term Expires | Expiration of Term for Which Nominated |
| Directors with Terms Expiring at the Annual Meeting/Nominees |       |     |                                                 |                |                      |                                        |
| Henry Ji, Ph.D.(4)(5)                                        | III   |  60 | Executive Chairperson and Director              |           2023 |                 2025 |                                   2028 |
| Jaisim Shah(4)(5)                                            | III   |  64 | Chief Executive Officer, President and Director |           2022 |                 2025 |                                   2028 |
| Continuing Directors                                         |       |     |                                                 |                |                      |                                        |
| Dorman Followwill(1)(2)(3)                                   | I     |  61 | Director                                        |           2022 |